thccbd

After failing in an ulcerative colitis test a few years back, GW Pharma's cannabis-derived orphan drug treatment has had better luck in a small oncology study for an aggressive type of brain tumor. In the phase 2 study, the U.K. biopharma's cannabidiol (CBD) and tetrahydrocannabinol (THC)...